Overall, these results reinforce the central role of insulin resistance in NAFLD development and highlight the potential of early insulin sensitization to significantly mitigate the hepatometabolic risks associated with increased body fat. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.